A Study of the Effects of Oxytocin in Adults With Binge-eating Disorder

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
Study staff will screen patients for eligibility as per eligibility criteria. At least 60eligible patients will be randomized 1:1 (active oxytocin: placebo) by an unblindedpharmacist. All other study staff and test subjects will be blinded. Study subjectmedical histories, physical exams, anthropometric measurements, labs, EKG's, and eatinghabits will be monitored over 8 weeks. Subjects will be evaluated at the followingintervals: Baseline, week 2, week 4, week 8, and week 16 (8 weeks post‐treatment).
Epistemonikos ID: adc15dc56193f91cd97680884a736b6d00ec6b6c
First added on: May 14, 2024